細胞治療用バイオプロセスは、2020 年の 111 億 9,250 万米ドルから 2028 年には 300 億 5,261 万米ドルに達すると予想されています。市場は 2021 年から 2028 年にかけて 13.5% の CAGR で成長すると推定されています。
細胞療法バイオプロセシング市場は、技術、細胞の種類、エンドユーザー、および地域に基づいて分析されています。地域に基づく市場は、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南米および中央アメリカに分割されています。このレポートは、細胞治療バイオプロセシング市場の洞察と詳細な分析を提供するために、市場動向、技術の進歩、市場力学、大手企業の競争状況分析などのパラメーターに重点を置いています。また、すべての主要地域の市場全体における新型コロナウイルス感染症のパンデミックの分析も含まれています。
細胞治療バイオプロセシング市場にとって有利な地域
市場洞察
細胞治療の承認が増加
細胞治療は、治療において肯定的な結果を示しています再生医療や個別化医療の提供により、希少な遺伝性疾患を含むさまざまな慢性疾患を治療します。慢性疾患を治療する必要性の高まりにより研究開発活動が推進され、その結果、細胞療法の生産と製品承認が増加しています。細胞治療バイオプロセシング市場の成長に貢献した細胞治療承認の例を以下にいくつか挙げます。
- 2019 年 5 月、食品医薬品局 (FDA) は、Novartis AG の子会社である AveXis, Inc. が製造した Zolgensma を承認しました。ゾルゲンサは 2 歳未満の小児の脊髄性筋萎縮症を治療するために設計されており、静脈内に 1 回注入することで投与されます。
- 2020 年 7 月、Gilead Company の子会社である Kite Pharma, Inc. は FDA の認可を受けました。 Tecartus の承認。 Tecartus は、成人の難治性マントル細胞リンパ腫 (MCL) を治療するために設計された (CAR) T 細胞療法です。 toe Gilead Company によると、Tecartus はマントル細胞リンパ腫に対して初めて承認された (CAR) T 細胞療法であり、マントル細胞リンパ腫治療の新境地となることが期待されています。
- 2021 年 2 月に、Juno が発表されました。ブリストル・マイヤーズ スクイブ社の子会社であるセラピューティクス社は、ブレヤンジの承認を取得しました。 Breyanzi は、成人における特定の種類の大細胞型 B 細胞リンパ腫の治療を目的とした細胞ベースの遺伝子治療です。この治療は、患者が他の少なくとも 2 種類の全身治療に反応しなかった後に行われます。しかし、ブレヤンジは2019年、最初の申請以来規制上の後退に直面した。現在、欧州医薬品庁の審査中であり、2020 年 7 月に検証されました。
このように、製品開発の成長により、細胞治療の増加を反映するさまざまな製品の承認がもたらされました。したがって、細胞療法の承認の増加により、細胞療法のバイオプロセスが大幅に増加し、それが今後数年間の市場の成長を促進すると予想されます。
テクノロジーベースの洞察
細胞治療バイオプロセシング市場は、技術別に、バイオリアクター、凍結乾燥、エレクトロスピニング、コントロールフロー遠心分離、超音波溶解、ゲノム編集技術、細胞不死化技術、ウイルスベクター技術に分割されています。バイオリアクターセグメントは2020年に市場で最大のシェアを保持したが、ゲノム編集テクノロジーセグメントは予測期間中に市場で最高のCAGR 14.5%を記録すると予想されている。
細胞治療バイオプロセシング市場、byテクノロジー - 2020 年と 2028 年
細胞タイプベースの洞察
細胞治療バイオプロセシング市場は、細胞タイプごとに、幹細胞、免疫細胞、ヒト胚性幹細胞、多能性幹細胞に分類されます。細胞、造血幹細胞。幹細胞セグメントは 2020 年に市場で最大のシェアを保持しましたが、同じセグメントは予測期間中に市場で 14.0% という最高の CAGR を記録すると予想されます。
エンドユーザーベースの洞察
p>
細胞治療バイオプロセシング市場は、適応症別に、心血管疾患 (CVD)、腫瘍学、創傷治癒、整形外科などに細分化されています。 2020 年には腫瘍学分野が市場で最大のシェアを占め、整形外科分野は予測期間中に市場で最高の CAGR 14.3% を記録すると予想されます。
戦略的洞察
細胞治療バイオプロセシング市場で事業を展開する企業は、世界中で自社の拠点と製品ポートフォリオを拡大し、増大する需要に対応するために、製品の発売や拡張などの有機的な戦略を採用しています。
テクノロジー別
< ul>
細胞タイプ別
- 幹細胞
- 免疫細胞
- ヒト胚性幹細胞
- 多能性幹細胞
- 造血幹細胞
適応症別< /p>
- 心血管疾患 (CVD)
- 腫瘍学
- 創傷治癒
- 整形外科
- その他
>
エンドユーザー別
- 病院および診療所
- 診断センター
- 再生医療センター
- 学術研究機関
地理別
- 北アメリカ
- 米国
- カナダ
- メキシコ
- ヨーロッパ
- フランス
- ドイツ
- イタリア
- 英国< /li>
- スペイン
- ヨーロッパのその他の地域
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- アジア太平洋地域のその他の地域
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- MEAの残りの部分
- 中南米 (SCAM)
- ブラジル
- アルゼンチン
- その他の SCAM
< /li> - フレゼニウス・カビ AG
- 旭化成株式会社
- ザルトリウス AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- コーニング社
- Cytiva
- ロンザ
- レプリゲン
- キャタレント株式会社
< li>中東およびアフリカ (MEA)
会社概要
li>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.
The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.
The List of Companies - Cell Therapy Bioprocessing Market
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)